MUMBAI (Reuters) – Dr Reddy’s Laboratories Ltd, India’s second-largest drugmaker by sales, said it will buy some established brands of Belgian drugmaker UCB SA in India, Nepal, Sri Lanka and Maldives for 8 billion rupees ($128.38 million).
Dr Reddy's to buy select brands from UCB for $128 million
No comments:
Post a Comment